203 related articles for article (PubMed ID: 36584795)
1. Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
Schepers M; Paes D; Tiane A; Rombaut B; Piccart E; van Veggel L; Gervois P; Wolfs E; Lambrichts I; Brullo C; Bruno O; Fedele E; Ricciarelli R; Ffrench-Constant C; Bechler ME; van Schaik P; Baron W; Lefevere E; Wasner K; Grünewald A; Verfaillie C; Baeten P; Broux B; Wieringa P; Hellings N; Prickaerts J; Vanmierlo T
Brain Behav Immun; 2023 Mar; 109():1-22. PubMed ID: 36584795
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
Syed YA; Baer A; Hofer MP; González GA; Rundle J; Myrta S; Huang JK; Zhao C; Rossner MJ; Trotter MW; Lubec G; Franklin RJ; Kotter MR
EMBO Mol Med; 2013 Dec; 5(12):1918-34. PubMed ID: 24293318
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.
Poon MM; Lorrain KI; Stebbins KJ; Edu GC; Broadhead AR; Lorenzana AO; Paulson BE; Baccei CS; Roppe JR; Schrader TO; Valdez LJ; Xiong Y; Chen AC; Lorrain DS
Sci Rep; 2024 May; 14(1):10573. PubMed ID: 38719983
[TBL] [Abstract][Full Text] [Related]
4. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
5. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
6. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
[TBL] [Abstract][Full Text] [Related]
7. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
[TBL] [Abstract][Full Text] [Related]
9. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase (PDE) 4 inhibition boosts Schwann cell myelination in a 3D regeneration model.
Schepers M; Malheiro A; Gamardo AS; Hellings N; Prickaerts J; Moroni L; Vanmierlo T; Wieringa P
Eur J Pharm Sci; 2023 Jun; 185():106441. PubMed ID: 37004962
[TBL] [Abstract][Full Text] [Related]
11. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.
Medina-Rodríguez EM; Bribián A; Boyd A; Palomo V; Pastor J; Lagares A; Gil C; Martínez A; Williams A; de Castro F
Sci Rep; 2017 Mar; 7():43545. PubMed ID: 28256546
[TBL] [Abstract][Full Text] [Related]
12. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation.
Melero-Jerez C; Fernández-Gómez B; Lebrón-Galán R; Ortega MC; Sánchez-de Lara I; Ojalvo AC; Clemente D; de Castro F
Glia; 2021 Apr; 69(4):905-924. PubMed ID: 33217041
[TBL] [Abstract][Full Text] [Related]
15. Teriflunomide promotes oligodendroglial differentiation and myelination.
Göttle P; Manousi A; Kremer D; Reiche L; Hartung HP; Küry P
J Neuroinflammation; 2018 Mar; 15(1):76. PubMed ID: 29534752
[TBL] [Abstract][Full Text] [Related]
16. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
17. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
[TBL] [Abstract][Full Text] [Related]
18. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a benzothiazole-based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis.
Benítez-Fernández R; Josa-Prado F; Sánchez E; Lao Y; García-Rubia A; Cumella J; Martínez A; Palomo V; de Castro F
CNS Neurosci Ther; 2024 Jan; 30(1):e14552. PubMed ID: 38287523
[TBL] [Abstract][Full Text] [Related]
20. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
